Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza,

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Texas , United States , , University Of Punjab , Corporate Medical Affairs At Verastem Oncology , Clinical Development At Salarius Pharmaceuticals , University Of Texas At Houston , America Medical Affairs At Sanofi Oncology , Aprea Therapeutics , Senior Vice President , Clinical Development , Salarius Pharmaceuticals , Corporate Medical Affairs , Verastem Oncology , Global Head , Solid Tumors , Abbvie Oncology , Vice President , North America Medical Affairs ,